4//SEC Filing
Neumayer Matthew Paul 4
Accession 0001179110-11-002824
CIK 0001360886other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 6:33 AM ET
Size
5.8 KB
Accession
0001179110-11-002824
Insider Transaction Report
Form 4
Neumayer Matthew Paul
Principal Accounting Officer
Transactions
- Award
Incentive Stock Option (right to buy)
2011-02-14$7.13/sh+4,000$28,520→ 14,000 totalExercise: $7.13From: 2012-02-14Exp: 2021-02-14→ Common Stock (4,000 underlying)
Footnotes (1)
- [F1]The option to purchase 4,000 shares of the common stock of Osiris Therapeutics, Inc. shall become exercisable with respect to the underlying shares as to 25% on each of February 14, 2012, 2013, 2014 and 2015, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.
Documents
Issuer
OSIRIS THERAPEUTICS, INC.
CIK 0001360886
Entity typeother
Related Parties
1- filerCIK 0001476315
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 6:33 AM ET
- Size
- 5.8 KB